STOCK TITAN

Caroline Baumal plans sale of 2,797 APLS shares (NASDAQ: APLS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A Form 144 notice indicates that Caroline R. Baumal plans to sell up to 2,797 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $60,877.82. These shares relate to restricted stock that vested on 01/21/2026 and were acquired from the issuer as compensation.

The planned sale is expected to occur around 01/22/2026 on the NASDAQ, and the filing notes that 126,525,218 shares of this class were outstanding. In the prior three months, Baumal sold additional common shares in two transactions totaling 4,902 shares, for gross proceeds of $77,096.67 and $37,250.24, respectively. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Apellis Pharmace

NASDAQ:APLS

View APLS Stock Overview

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.41B
107.36M
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM